471 related articles for article (PubMed ID: 24021978)
1. Ceramide synthases as potential targets for therapeutic intervention in human diseases.
Park JW; Park WJ; Futerman AH
Biochim Biophys Acta; 2014 May; 1841(5):671-81. PubMed ID: 24021978
[TBL] [Abstract][Full Text] [Related]
2. The effect of altered sphingolipid acyl chain length on various disease models.
Park WJ; Park JW
Biol Chem; 2015 Jun; 396(6-7):693-705. PubMed ID: 25720066
[TBL] [Abstract][Full Text] [Related]
3. Eleven residues determine the acyl chain specificity of ceramide synthases.
Tidhar R; Zelnik ID; Volpert G; Ben-Dor S; Kelly S; Merrill AH; Futerman AH
J Biol Chem; 2018 Jun; 293(25):9912-9921. PubMed ID: 29632068
[TBL] [Abstract][Full Text] [Related]
4. Expression of Ceramide Synthases in Mice and Their Roles in Regulating Acyl-Chain Sphingolipids: A Framework for Baseline Levels and Future Implications in Aging and Disease.
Richardson WJ; Humphrey SB; Sears SM; Hoffman NA; Orwick AJ; Doll MA; Doll CL; Xia C; Hernandez-Corbacho M; Snider JM; Obeid LM; Hannun YA; Snider AJ; Siskind LJ
Mol Pharmacol; 2024 Feb; 105(3):131-143. PubMed ID: 38164625
[TBL] [Abstract][Full Text] [Related]
5. Ceramide Synthases Are Attractive Drug Targets for Treating Metabolic Diseases.
Raichur S
Front Endocrinol (Lausanne); 2020; 11():483. PubMed ID: 32849276
[TBL] [Abstract][Full Text] [Related]
6. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.
Laviad EL; Albee L; Pankova-Kholmyansky I; Epstein S; Park H; Merrill AH; Futerman AH
J Biol Chem; 2008 Feb; 283(9):5677-84. PubMed ID: 18165233
[TBL] [Abstract][Full Text] [Related]
7. Defective ceramide synthases in mice cause reduced amplitudes in electroretinograms and altered sphingolipid composition in retina and cornea.
Brüggen B; Kremser C; Bickert A; Ebel P; Vom Dorp K; Schultz K; Dörmann P; Willecke K; Dedek K
Eur J Neurosci; 2016 Jul; 44(1):1700-13. PubMed ID: 27086873
[TBL] [Abstract][Full Text] [Related]
8. Ceramide metabolism in mouse tissue.
Schiffmann S; Birod K; Männich J; Eberle M; Wegner MS; Wanger R; Hartmann D; Ferreiros N; Geisslinger G; Grösch S
Int J Biochem Cell Biol; 2013 Aug; 45(8):1886-94. PubMed ID: 23792024
[TBL] [Abstract][Full Text] [Related]
9. The long and the short of ceramides.
Wattenberg BW
J Biol Chem; 2018 Jun; 293(25):9922-9923. PubMed ID: 29934368
[TBL] [Abstract][Full Text] [Related]
10. Ceramide synthases at the centre of sphingolipid metabolism and biology.
Mullen TD; Hannun YA; Obeid LM
Biochem J; 2012 Feb; 441(3):789-802. PubMed ID: 22248339
[TBL] [Abstract][Full Text] [Related]
11. A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways.
Pewzner-Jung Y; Park H; Laviad EL; Silva LC; Lahiri S; Stiban J; Erez-Roman R; Brügger B; Sachsenheimer T; Wieland F; Prieto M; Merrill AH; Futerman AH
J Biol Chem; 2010 Apr; 285(14):10902-10. PubMed ID: 20110363
[TBL] [Abstract][Full Text] [Related]
12. The sphingolipid salvage pathway in ceramide metabolism and signaling.
Kitatani K; Idkowiak-Baldys J; Hannun YA
Cell Signal; 2008 Jun; 20(6):1010-8. PubMed ID: 18191382
[TBL] [Abstract][Full Text] [Related]
13. Selective knockdown of ceramide synthases reveals complex interregulation of sphingolipid metabolism.
Mullen TD; Spassieva S; Jenkins RW; Kitatani K; Bielawski J; Hannun YA; Obeid LM
J Lipid Res; 2011 Jan; 52(1):68-77. PubMed ID: 20940143
[TBL] [Abstract][Full Text] [Related]
14. Ceramide synthases: Reflections on the impact of Dr. Lina M. Obeid.
Kim JL; Mestre B; Shin SH; Futerman AH
Cell Signal; 2021 Jun; 82():109958. PubMed ID: 33607256
[TBL] [Abstract][Full Text] [Related]
15. Assaying Ceramide Synthase Activity In Vitro and in Living Cells Using Liquid Chromatography-Mass Spectrometry.
Lim XY; Pickford R; Don AS
Methods Mol Biol; 2016; 1376():11-22. PubMed ID: 26552671
[TBL] [Abstract][Full Text] [Related]
16. Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression.
Dai L; Trillo-Tinoco J; Bai A; Chen Y; Bielawski J; Del Valle L; Smith CD; Ochoa AC; Qin Z; Parsons C
Oncotarget; 2015 Sep; 6(27):24246-60. PubMed ID: 26327294
[TBL] [Abstract][Full Text] [Related]
17. An overview of sphingolipid metabolism: from synthesis to breakdown.
Gault CR; Obeid LM; Hannun YA
Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643
[TBL] [Abstract][Full Text] [Related]
18. Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent-resistant membranes.
Park JW; Park WJ; Kuperman Y; Boura-Halfon S; Pewzner-Jung Y; Futerman AH
Hepatology; 2013 Feb; 57(2):525-32. PubMed ID: 22911490
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and degradation pathways, functions, and pathology of ceramides and epidermal acylceramides.
Kihara A
Prog Lipid Res; 2016 Jul; 63():50-69. PubMed ID: 27107674
[TBL] [Abstract][Full Text] [Related]
20. Sphingolipids' role in radiotherapy for prostate cancer.
Hajj C; Haimovitz-Friedman A
Handb Exp Pharmacol; 2013; (216):115-30. PubMed ID: 23563654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]